Open Access

MicroRNA‑100 inhibits breast cancer cell proliferation, invasion and migration by targeting FOXA1

  • Authors:
    • Haihui Xie
    • Ruobing Xiao
    • Yaolin He
    • Lingzhi He
    • Changjun Xie
    • Juan Chen
    • Yan Hong
  • View Affiliations

  • Published online on: October 1, 2021
  • Article Number: 816
  • Copyright: © Xie et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


MicroRNAs (miRNAs/miRs) are highly conserved single‑stranded small non‑coding RNAs, which are involved in the physiological and pathological processes of breast cancer, and affect the prognosis of patients with breast cancer. The present study used the Gene Expression Omnibus (GEO)2R tool to detect miR‑100 expression in breast cancer tissues obtained from GEO breast cancer‑related datasets. Bioinformatics analysis revealed that miR‑100 expression was downregulated in different stages, grades and lymph node metastasis stages of breast cancer, and patients with high miR‑100 expression had a more favorable prognosis. Based on these analyses, Cell Counting Kit‑8, wound healing and Transwell assays were performed, and the results demonstrated that overexpression of miR‑100 inhibited the proliferation, migration and invasion of breast cancer cells. To verify the tumor‑suppressive effect of miR‑100 in breast cancer, the LinkedOmics and PITA databases were used to assess the association between miR‑100 and forkhead box A1 (FOXA1). The results demonstrated that miR‑100 had binding sites within the FOXA1 gene, and FOXA1 expression was negatively associated with miR‑100 expression in breast cancer tissues. Similarly, a negative association was observed between miR‑100 and FOXA1 expression, using the StarBase V3.0 database. The association between miR‑100 and FOXA1 was further verified via reverse transcription‑quantitative PCR and western blot analyses, and the dual‑luciferase reporter assay. The results demonstrated that miR‑100 targeted the 3'‑untranslated region of FOXA1 in breast cancer cells. Furthermore, rescue experiments were performed to confirm whether miR‑100 exerts its antitumor effects by regulating FOXA1. The results demonstrated that overexpression of FOXA1 promoted the proliferation, migration and invasion of breast cancer cells; thus, the antitumor effects of miR‑100 in breast cancer were reversed following overexpression of FOXA1. Taken together, the results of the present study suggest that miR‑100 inhibits the proliferation, migration and invasion of breast cancer cells by targeting FOXA1 expression. These results may provide a novel insight and an experimental basis for identifying effective therapeutic targets of high specificity for breast cancer.
Something has gone wrong

HTTP Error 400

Well this is embarrassing. Something has gone wrong. Hopefully it is a transient error that will go away if you retry.

If the problem persists if you email our System Administrators letting them know what you were doing and telling them it was because:

Exception evaluating SpringEL expression: "dispArt?.images" (template: "article" - line 384, col 9)

and then they can get to work fixing it